A multi-center, double blind, placebo-controlled flexible dose study to evaluate the efficacy and safety of Paroxetine in children with major depression.
Major Depressive Disorder
Phase 3
The data from this study is provided in combined datasets containing data from other paroxetine studies. An annotated case report form is not available for this study. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
May 2014